Non-Hodgkin Lymphoma Clinical Trials in Aurora, Colorado

8 studies are recruiting for non-hodgkin lymphoma in Aurora, Colorado right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma

    This study is a Phase 1 multicenter study with a Dose Escalation and Dose Expansion evaluating safety and efficacy of MT-601 administration to patients with Relapsed or Refractory Lymphoma. The starting dose administered is 200 x 10\^6 cells (flat dosing).

    Stage
    Phase 1
    Ages
    18 to 100
    Site
    University of Colorado, Aurora, Colorado
    Locations
    7 in total
    Run by
    Marker Therapeutics, Inc.
  2. A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

    This Phase 3 study compares rondecabtagene autoleucel (ronde-cel), a dual-targeting CD19/CD20 CAR T-cell therapy, with investigator's choice of CD19 CAR T-cell therapy in patients with relapsed or refractory large B-cell lymphoma in the second-line setting.

    Stage
    Phase 3
    Ages
    18 and older
    Site
    University of Colorado, Aurora, Colorado
    Locations
    36 in total
    Run by
    Lyell Immunopharma, Inc.
  3. Preliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL Patients

    This open-label, single arm phase 1 trial aims to determine the safety and tolerability of anti-CD19 and anti-CD22 chimeric antigen receptor-expressing (CAR) T cells (CD19x22 CAR T) in adolescents and adults with relapsed/refractory (R/R) B-cell Non-Hodgkin Lymphoma (B-NHL). This trial will determi…

    Stage
    Phase 1
    Ages
    16 and older
    Site
    University of Colorado Hospital, Aurora, Colorado
    Run by
    University of Colorado, Denver
  4. A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

    This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications.

    Stage
    Not phased
    Ages
    Any age
    Site
    Children's Hospital Colorado, Aurora, Colorado
    Locations
    142 in total
    Run by
    Center for International Blood and Marrow Transplant Research
  5. Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

    The use of venetoclax-based therapies for pediatric patients with relapsed or refractory malignancies is increasingly common outside of the clinical trial setting. For patients who cannot swallow tablets, it is common to crush the tablets and dissolve them in liquid to create a solution. However, n…

    Stage
    Not phased
    Ages
    0 to 38
    Site
    Children's Hospital Colorado, Aurora, Colorado
    Locations
    5 in total
    Run by
    Children's Hospital Medical Center, Cincinnati
  6. Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

    This is a multi-site clinical study enrolling 2000 newly diagnosed patients with breast, colorectal, melanoma, non-Hodgkin lymphoma, or non-small cell lung cancer, who are planning to receive one or more systemic cancer directed therapies with chemotherapy and/or (immune checkpoint inhibitors) ICIs.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Rocky Mountain Cancer Centers-Aurora, Aurora, Colorado
    Locations
    467 in total
    Run by
    Wake Forest University Health Sciences
  7. Improving Communication and Building a Stronger Medical Home Among Spanish-speaking Families

    This study will seek to improve communication with Spanish speaking families and patients with Cancer and Blood Disorders.

    Stage
    Not phased
    Ages
    Up to 22
    Site
    Children's Hospital Colorado, Aurora, Colorado
    Run by
    University of Colorado, Denver
  8. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

    International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinical impact on pts with advanced cancer to facilitate clinical…

    Stage
    Not phased
    Ages
    Any age
    Site
    Massive Bio SYNERGY-AI site, Aurora, Colorado
    Locations
    68 in total
    Run by
    Massive Bio, Inc.

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.